Downstream phosphorylation and activation of ERα, prompted by EGF, is believed to induce the proliferation of breast cancer cells, by triggering a unique chromatin‐binding pattern in cooperation with other transcription factor complexes [66]. Here, ESR1 is linked to breast cancer.